Navigation Links
3SBio Inc. Announces Unaudited Second Quarter 2009 Results
Date:8/11/2009

/a> and at http://tinyurl.com/l8hs96 . A replay of the webcast will be available within one hour after the conclusion of the call.

Non-GAAP Financial Measures: Reconciliation of GAAP to Non-GAAP

To supplement the Company's financial information presented in accordance with general accepted accounting principles ("GAAP"), the Company has utilized some non-GAAP financial measures to provide investors and management with supplemental measures that facilitate comparisons of operating performance and trends with prior and future operating performance, and that may not otherwise be apparent on a GAAP basis. These non-GAAP financial measures include non- GAAP net income, non-GAAP net income per share, non-GAAP net income per ADS, non-GAAP operating income, non-GAAP operating expenses, non-GAAP gross profit etc. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principals, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations as determined in accordance with GAAP. These measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures. Please see the attached reconciliation of GAAP to non-GAAP for an explanation of the amounts excluded to arrive at non-GAAP financial measures for the three-month periods ended June 30, 2008 and June 30, 2009 and for the six month periods ended June 30, 2009 and June 30, 2008.

Statement Regarding Unaudited Financial Information

The unaudited financial information set for
'/>"/>

SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
2. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
3. 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
4. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
5. 3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference
6. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
7. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
8. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Leading Medical Developer Announces Plans for Texoma Medical Plaza
10. iMedX Announces Investment of $13M From RFE Investment Partners
11. Health Market Science Announces Commercial Release of CompleteSpend V2.5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AM,Ala.,Nov.24/PRNewswire-FirstCall/--HealthSouthC...ateintheBankofAmericaMerrillLynch2009CreditConfere...rVicePresidentandTreasurerEdFaywillbespeakingonThu...ewebcastliveandwillbeavailableat http://investor.h... AboutHealthSouth ,, HealthSouthisthenation,sl...
(Date:11/24/2009)...at pose choking hazard, are too loud, or contain d...(HealthDay News) -- As the holiday shopping season...toys are still being sold in stores across the Uni... annual Trouble in Toyland report, released Tues...RG). , The report focuses on toys that pose a c...
(Date:11/24/2009)...ibutes to the falls that plague older adults, stud...y News) -- Falls are a leading cause of death amon...chronic pain contributes to those accidents. , ... weakness, and is associated with mobility limitat...hors wrote. , "Chronic pain, no matter how we m...
(Date:11/24/2009)...n example, study finds no added use but higher cos... -- Direct-to-consumer drug ads may contribute to ...at examined sales of the widely used antiplatelet ...ta from 1999 to 2005 for 27 state Medicaid program...opidogrel did not increase people,s use of the dru...
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--Thereisanewgameinto...reduction,offeringpragmaticandrealisticstrategiesw...ed.SpearheadingthismovementisagroupcalledHAMS--Har...AMSisafree-of-charge,lay-ledsupportandinformationa...nstituteonAlcoholAbuseandAlcoholismtellsusthatonly...
Breaking Medicine News(10 mins):Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:Advertising to Consumers May Raise Drug Prices 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2
...ernors and Mayors Support Event, ALEXANDRIA, Va.,...ealthcare Decisions Day (NHDD), will be the larges... professionals about,advance healthcare planning.,...are Decisions Day. "All Americans should use April...
...hm-Stecher, assistant professor in food science an... with tiny particles. His latest research project ...ver nanoparticles to improve the safety of the wor...such as microbe-resistant fabrics or non-biofoulin...
...il 10 Hooper Holmes,(Amex: HH ) today announced ... Chief Executive Officer and that Benjamin A. Curr...ctors. Mr. Bubbs, who has been a member of the,Boa...usly been named Chairman-Elect,continues as Chairm...
...fied opinion in Type II examination by independent...LLE, Colo., April 10 GHX has received an,unqualif...of its first Type,II SAS 70 compliance audit. The ...ed GHX,s exchange services, which,enable more than...
...y David Spiegel of Faculty of 1000 Medicine ( www....ween depression care management and survival rates...nt and well-conducted study of the effects of trea... sciences at Stanford University, Spiegel evaluate...
...ntries for the eighth,annual Michael E. DeBakey Jo...iomedical Research (FBR) and named after FBR,s cha...s open to all professional journalists whose repor...Dr. DeBakey,s many inventions and innovations have...
Other Medicine News:Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3Health News:GHX Achieves SAS 70 Compliance 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2
(Date:11/24/2009)...rstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX ...ecutiveOfficerofNeurocrineBiosciences,willbepresen...einNewYork. ,, ThelivepresentationtakesplaceTue....m.PacificTime(PT).Thepresentationwillbesimultaneo... http://www.neurocrine.com . ,, Ifyouareunablet...
(Date:11/24/2009)...Newswire/--SatelliteHealthcare,oneofthenation,sfir...ajorsponsorofnephrologyresearch,todayannounceditsf...lahinhisefforttosupporttheSanJosehomelessthisThank...ulcareerasachefforthepast20years.ButNasrallah,slif...edwithEndStageRenalDisease(ESRD).Thediagnosisirrev...
(Date:11/24/2009)...rstCall/--Orexigen®Therapeutics,Inc.(Nasdaq: ...entofobesity,todayannouncedthatonNovember18,2009th...rsgrantedaninducementstockoptiontopurchase200,000s...pointedHeadoftheGlobalContraveProgram. ,, Thest...extentpermittedbylawandhasanexercisepricepersharee...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 1Fate Therapeutics Closes 2430 Million Series B Financing 14844 2Fate Therapeutics Closes 2430 Million Series B Financing 14844 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 4Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3China Medicine Announces Strong Third Quarter 2009 Results 6275 1China Medicine Announces Strong Third Quarter 2009 Results 6275 2China Medicine Announces Strong Third Quarter 2009 Results 6275 3China Medicine Announces Strong Third Quarter 2009 Results 6275 4China Medicine Announces Strong Third Quarter 2009 Results 6275 5China Medicine Announces Strong Third Quarter 2009 Results 6275 6China Medicine Announces Strong Third Quarter 2009 Results 6275 7China Medicine Announces Strong Third Quarter 2009 Results 6275 8China Medicine Announces Strong Third Quarter 2009 Results 6275 9China Medicine Announces Strong Third Quarter 2009 Results 6275 10China Medicine Announces Strong Third Quarter 2009 Results 6275 11China Medicine Announces Strong Third Quarter 2009 Results 6275 12China Medicine Announces Strong Third Quarter 2009 Results 6275 13China Medicine Announces Strong Third Quarter 2009 Results 6275 14China Medicine Announces Strong Third Quarter 2009 Results 6275 15
...., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WY...inistration,s (FDA),San Juan District Office has i...ion of its Guayama, Puerto Rico manufacturing,faci... of the site.,The new classification means that an...ed by the Company or do not merit any further,regu...
...taminated with Diethylene Glycol,(DEG) Remains a P..., Md., May 4, 2007-The U.S. Food and Drug,Administ...rs,suppliers, drug repackers, and health professi...gilant in assuring that glycerin, a,sweetener comm...,prescription drug products, is not contaminated w...
Other Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
511 Lightweight Pneumatic Conserver
...Conserver., ,Offers an average 5:1 increase in us...standard cannula. , ,The combination of the OXYMA...ulatory oxygen patients a superior alternative to ...warranty. , ,NOTE: Each model has passed the ...
WAVE 6203
...afts For Insertion Through A 1.0mm Incision., ,... Improved Ergonomics., ,Curved Shafts F...s For Improved Sub-Incisional Flap Purchase., ,...ring Sterilization., ,Reusable, Autoclaveable,...
Medicine Products: